4-25662599-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_006424.3(SLC34A2):āc.99A>Gā(p.Lys33=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000811 in 1,614,154 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.0045 ( 4 hom., cov: 32)
Exomes š: 0.00043 ( 6 hom. )
Consequence
SLC34A2
NM_006424.3 synonymous
NM_006424.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.572
Genes affected
SLC34A2 (HGNC:11020): (solute carrier family 34 member 2) The protein encoded by this gene is a pH-sensitive sodium-dependent phosphate transporter. Phosphate uptake is increased at lower pH. Defects in this gene are a cause of pulmonary alveolar microlithiasis. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 4-25662599-A-G is Benign according to our data. Variant chr4-25662599-A-G is described in ClinVar as [Benign]. Clinvar id is 2042856.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.572 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00448 (682/152262) while in subpopulation AFR AF= 0.0157 (651/41544). AF 95% confidence interval is 0.0147. There are 4 homozygotes in gnomad4. There are 317 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC34A2 | NM_006424.3 | c.99A>G | p.Lys33= | synonymous_variant | 2/13 | ENST00000382051.8 | NP_006415.3 | |
SLC34A2 | NM_001177998.2 | c.99A>G | p.Lys33= | synonymous_variant | 2/13 | NP_001171469.2 | ||
SLC34A2 | NM_001177999.2 | c.99A>G | p.Lys33= | synonymous_variant | 2/13 | NP_001171470.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC34A2 | ENST00000382051.8 | c.99A>G | p.Lys33= | synonymous_variant | 2/13 | 1 | NM_006424.3 | ENSP00000371483 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00447 AC: 680AN: 152144Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
680
AN:
152144
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00101 AC: 254AN: 251484Hom.: 3 AF XY: 0.000780 AC XY: 106AN XY: 135914
GnomAD3 exomes
AF:
AC:
254
AN:
251484
Hom.:
AF XY:
AC XY:
106
AN XY:
135914
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000429 AC: 627AN: 1461892Hom.: 6 Cov.: 32 AF XY: 0.000355 AC XY: 258AN XY: 727246
GnomAD4 exome
AF:
AC:
627
AN:
1461892
Hom.:
Cov.:
32
AF XY:
AC XY:
258
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00448 AC: 682AN: 152262Hom.: 4 Cov.: 32 AF XY: 0.00426 AC XY: 317AN XY: 74450
GnomAD4 genome
AF:
AC:
682
AN:
152262
Hom.:
Cov.:
32
AF XY:
AC XY:
317
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
SLC34A2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 17, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 22, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at